The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency
Tóm tắt
Từ khóa
Tài liệu tham khảo
Török, 1995, Increasing mortality from thrombotic thrombocytopenic purpura in the United States – analysis of national mortality data, 1968–1991, Am J Hematol, 50, 84, 10.1002/ajh.2830500203
Sington, 2002, Analysis of the sensitivity of death certificates in 440 hospital deaths: a comparison with necropsy findings, J Clin Pathol, 55, 499, 10.1136/jcp.55.7.499
Amorosi, 1966, Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature, Medicine (Baltimore), 45, 139, 10.1097/00005792-196603000-00003
Rock, 1991, Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura, New Engl J Med, 325, 393, 10.1056/NEJM199108083250604
Miller, 2004, Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, Epidemiology, 15, 208, 10.1097/01.ede.0000113273.14807.53
Vesely, 2003, ADAMTS‐13 activity in thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients, Blood, 101, 60, 10.1182/blood-2003-01-0193
George, 2004, The Oklahoma thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome (TTP‐HUS) registry: a community perspective of patients with clinically diagnosed TTP‐HUS, Semin Hematol, 41, 60, 10.1053/j.seminhematol.2003.10.001
George, 2000, How I treat patients with thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome, Blood, 96, 1223, 10.1182/blood.V96.4.1223
US Census Bureau. Census 2000 Summary File 2; using American Fact Finder. Available at: http://factfinder.census.gov, accessed on August 27, 2004.
Clark, 2003, Effect of awareness of a randomized controlled trial on use of experimental therapy, JAMA, 290, 1351, 10.1001/jama.290.10.1351
Greenland, 1998, Introduction to stratified analysis
Furlan, 1998, von Willebrand factor‐cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic‐uremic syndrome, New Engl J Med, 339, 1578, 10.1056/NEJM199811263392202
Bianchi, 2002, von Willebrand factor‐cleaving protease (ADAMTS‐13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura, Blood, 100, 710, 10.1182/blood-2002-02-0344
Tripodi, 2004, Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas, J Thromb Haemost, 2, 1601, 10.1111/j.1538-7836.2004.00879.x
Whitelock, 2004, ADAMTS‐13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF‐A2 domain as substrate, J Thromb Haemost, 2, 485, 10.1111/j.1538-7836.2004.00601.x
Zheng, 2004, Effect of plasma exchange on plasma ADAMTS‐13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and non‐idiopathic thrombotic thrombocytopenic purpura, Blood, 103, 4043, 10.1182/blood-2003-11-4035
Furlan, 2001, Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor‐cleaving protease, Best Pract Res Clin Haematol, 14, 437, 10.1053/beha.2001.0142
George, 2003, The association of pregnancy with thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome, Curr Opin Hematol, 10, 339, 10.1097/00062752-200309000-00003
Conlon, 1995, The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults, Nephrol Dial Transplant, 10, 1189
Elkins, 1996, Thrombotic thrombocytopenic purpura: evolution across 15 years, J Clin Apheresis, 11, 173, 10.1002/(SICI)1098-1101(1996)11:4<173::AID-JCA1>3.0.CO;2-8
McCarty, 1995, Incidence of systemic lupus erythematosus: race and gender differences, Arthritis Rheum, 38, 1260, 10.1002/art.1780380914